Plain-language summary
The defining review of the N-acetylcarnosine eye-drop literature, written by the program's lead investigator. It covers why a topical prodrug is required to reach the lens, the trial evidence behind glare and visual-acuity improvements, and the unresolved questions clinicians still ask about long-term use.
Key takeaways
- ›Explains why the prodrug N-acetylcarnosine is necessary for ocular delivery.
- ›Consolidates the clinical evidence in one reference.
- ›Defines the open questions for future ocular trials.
About this summary
The summary and key takeaways above are written by our editorial team in plain language for general readers. They are not the original abstract. For the authors' own wording, methodology, statistics, and full reference list, follow the source link to the published record.